TRIODOS BANK NV (TRIO.AS) Stock Earnings Estimates

Europe • Euronext Amsterdam • AMS:TRIO • NL0010407946

29.25 EUR
+0.1 (+0.34%)
Last: Feb 6, 2026, 07:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TRIO.AS revenue by date.TRIO.AS revenue by date.
390.152M
10.53%		483.938M
24.04%		478.534M
-1.12%		465.04M
-2.82%		467.24M
0.47%		469.33M
0.45%		476.58M
1.54%
EBITDA
YoY % growth
TRIO.AS ebitda by date.TRIO.AS ebitda by date.
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TRIO.AS ebit by date.TRIO.AS ebit by date.
N/AN/AN/A84.876M102.85M
21.18%		101.34M
-1.47%		121.34M
19.74%
Operating Margin
TRIO.AS operating margin by date.TRIO.AS operating margin by date.
N/AN/AN/A18.25%22.01%21.59%25.46%
EPS
YoY % growth
TRIO.AS eps by date.TRIO.AS eps by date.
N/AN/AN/A1.094.56
319.72%		5.08
11.52%		5.17
1.64%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
TRIO.AS Yearly EPS VS EstimatesTRIO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 1 2 3 4 5
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 225.91M
-6.59%		%
Q4 2024
Q2Q % growth		 237.004M
-3.08%		%
Q2 2024
Q2Q % growth		 241.848M
0.74%		%
TRIO.AS Yearly Revenue VS EstimatesTRIO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A